The biotech index is more than a triple bagger ramp since 2010.

By |2014-12-05T15:45:24+00:00December 5th, 2014|Pharma News|

The biotech index is more than a triple bagger ramp since 2010. Know that as long as the biopharm has equity (capital), research will continue with reckless abandon. Hopefully, with this ramp, the old guard will implement technology to bring more accurate outcomes. szimm

Read More
Comments Off on The biotech index is more than a triple bagger ramp since 2010.

FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:

By |2014-12-05T15:36:09+00:00December 5th, 2014|Pharma News|

The biotech index is more than a triple bagger ramp since 2010. As a student of the market for over 20 years, with clinical research funding dropping, is there a top anywhere in sight? SZIMM Exclusive Interview with David Nierengarten, Ph.D., an Analyst at Wedbush Securities Covering the Biotechnology and Biopharmaceuticals Sector TWST: What's the FDA [...]

Read More
Comments Off on FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:
Go to Top